Ibiglustat

≥99%

  • Product Code: 100897
  CAS:    1401090-53-6
Molecular Weight: 389.49 g./mol Molecular Formula: C₂₀H₂₄FN₃O₂S
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: Ibiglustat is primarily used in the treatment of Gaucher disease, a genetic disorder characterized by the accumulation of glucocerebroside in cells and certain organs. It works by inhibiting the enzyme glucosylceramide synthase, which reduces the production of glucocerebroside, thereby alleviating the symptoms associated with the disease. This compound is particularly beneficial for patients who do not respond well to enzyme replacement therapy or substrate reduction therapy. Additionally, ibiglustat is being investigated for its potential therapeutic effects in other lysosomal storage disorders and neurodegenerative diseases, offering hope for broader applications in the future.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.002 10-20 days £255.26
+
-
0.005 10-20 days £510.51
+
-
Ibiglustat
Ibiglustat is primarily used in the treatment of Gaucher disease, a genetic disorder characterized by the accumulation of glucocerebroside in cells and certain organs. It works by inhibiting the enzyme glucosylceramide synthase, which reduces the production of glucocerebroside, thereby alleviating the symptoms associated with the disease. This compound is particularly beneficial for patients who do not respond well to enzyme replacement therapy or substrate reduction therapy. Additionally, ibiglustat is being investigated for its potential therapeutic effects in other lysosomal storage disorders and neurodegenerative diseases, offering hope for broader applications in the future.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: £0.00
£0.00 Total :